Diabetes Tools Sweden AB

Triabetes clinical study interim results from Karolinska Institutet diabetes professor

News   •   Sep 29, 2014 11:00 GMT

Diabetes app study seminar with Professor Kerstin Brismar

Stockholm – Findings from the first six months of a clinical study which uses medtech firm Diabetes Tools’ Triabetes® smartphone app at diabetes clinics in Poland are being revealed by Professor Kerstin Brismar, from Stockholm’s Karolinska Institutet, on 10 October 2014.

Speaking at a seminar for delegates attending the October meeting of the Swedish Society for Diabetology, Professor Brismar will share interim results from a controlled study of 226 patients with Type 2 diabetes which is comparing the health outcomes, such as blood sugar control, of patients who use the Triabetes app with those who do not.

This two-year study is backed by academics from the Medical University of Warsaw and Karolinska Institutet. It is being conducted at multiple primary care clinics run by the managed care group Medicover in Poland. Indeed, the Medical Director of Medicover Dr. Piotr Soszynski is also speaking at the seminar. He will present how Triabetes, with its remote patient monitoring system, is used in day-to-day clinical practice.  

The seminar is a satellite event to the Swedish Society for Diabetology’s autumn meeting in Stockholm (9-10 October 2014) and is hosted by Diabetes Tools and healthcare diagnostic company A. Menarini Diagnostics.

  • Event: “Benefits of diabetes apps – preliminary clinical results”, Münchenbryggeriet, Stockholm
  • Date and time: 10 October 2014, from 12:00-13:30, including buffet lunch
  • Session 1:
  • When: 12:30-12:45
  • What: Presentation titled “Triabetes – mobile diabetes management in clinical practice”
  • Who: Piotr Soszynski MD Ph.D, Medical Director of Medicover
  • Session 2:
  • When: 12:45-13:05
  • What: Presentation titled “Triabetes – preliminary study results”
  • Who: Kerstin Brismar, Professor of diabetes research at Karolinska Institutet.

More information, including the seminar registration form for Swedish Society for Diabetology meeting delegates, is available at http://www.jamlikvard2014.se/program.asp.

Triabetes is a registered trademark of Diabetes Tools Sweden AB.

About Triabetes and Diabetes Tools

Triabetes is a smartphone app and online decision support service for people living with and caring for all forms of diabetes. Triabetes is from Diabetes Tools, a Swedish medical technology company that develops scientifically based Software-as-a-Service solutions. Triabetes is scalable. It can be used by individuals, doctors and treatment clinics, and can be integrated with large-scale Electronic Medical Record (EMR) systems.

Founded in 2005, Diabetes Tools is a privately held company located in Stockholm, Sweden. Diabetes Tools holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services. Triabetes is a CE-marked medical software product registered for sale in the European Union. More information at http://www.diabetestools.se.